Get a reply from this employer — a resume and cover letter tailored to exactly what they’re hiring for.
Summit Therapeutics is seeking a Director of Clinical Operations Analytics & Performance Excellence to lead the global analytics strategy for our oncology portfolio. You will own operational performance analytics, governance, and Veeva Vault Clinical excellence, translating data into insights that improve study execution, resource planning, and inspection readiness.
You will partner with IT, Biostatistics, RBM, and study teams to build scalable analytics, dashboards, and governance that enable
Remote
About Summit:
Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence.
Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including:
Non-small Cell Lung Cancer (NSCLC)
HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI.
HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC.
HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC.
HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy.
Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland.
Overview of Role:
The Director, Clinical Operations Analytics & Performance Excellence leads the analytics strategy for the global clinical trial portfolio and serves as the business owner for operational performance analytics, metrics, portfolio reporting, Clinical Operations data governance, and Veeva Vault Clinical capabilities. This role functions as the Clinical Operations subject matter expert (SME) for the Veeva Vault Clinical platform, ensuring alignment between business processes, system capabilities, data standards, and operational reporting requirements. The Director translates operational data into actionable insights to improve study execution, portfolio predictability, resource planning, site performance, inspection readiness, and risk-based decision-making.
This leader transforms operational data into strategic insights that improve study execution, portfolio predictability, resource planning, site performance, inspection readiness, and risk-based decision-making across the organization. Serving as the business lead and SME for Veeva Vault Clinical, the Director drives platform optimization, user adoption, process standardization, governance, and integration with the broader clinical technology ecosystem. Partnering with Clinical Operations, IT, Data Management, Biostatistics, RBM, Study Start-Up, Clinical Trial Management, and executive leadership, the Director develops scalable analytics capabilities and operational systems that enable data-driven study oversight and portfolio management. The role advances standardized data practices and leverages AI, automation, predictive analytics, and modern clinical technology platforms to support portfolio growth, operational excellence, and continuous process improvement.
Role and Responsibilities:
Clinical Operations Analytics Strategy
Performance Excellence & Portfolio Performance Analytics
Clinical Operations Data Governance & Data Quality
Clinical Analytics Technology Enablement
Process Excellence & Continuous Improvement
Leadership & Cross-Functional Collaboration
Required Experience, Education and Specialized Knowledge and Skills:
Preferred
This is the pay for this position
Pay Transparency
$190,000 - $237,000 USD
Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation.
Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit’s Talent Acquisition team at recruiting@smmttx.com to obtain prior written authorization before referring any candidates to Summit.
Summit Therapeutics Inc.is an Equal Opportunity Employer and takes pride in creating and maintaining diverse environment. We do not discriminate in recruitment, hiring, training or promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status.
For government reporting purposes, we ask candidates to respond to the below self-identification survey.Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiringprocess or thereafter. Any information that you do provide will be recorded and maintained in aconfidential file.
As set forth in Summit Therapeutics’s Equal Employment Opportunity policy,we do not discriminate on the basis of any protected group status under any applicable law.
If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection.As a government contractor subject to the Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measurethe effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categoriesis as follows:
A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service-connected disability.
A "recently separated veteran" means any veteran during the three-year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.
An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.
An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.